Enfektif endokardit (EE), kalp kapakçıklarının veya endokardiyumun, çoğunlukla doğuştan veya kazanılmış kalp kusurlarıyla ilişkili, nadir görülen ancak yaşamı tehdit eden bir mikrobiyal enfeksiyondur. Normal ağız florasında bulunan oral streptokokların, EE vakalarının %10-30'unu oluşturduğu bilinmektedir. Kötü ağız hijyeni, periodontal hastalıklar, dental prosedürler veya normal günlük aktiviteler (örneğin diş fırçalama) sırasında ortaya çıkan geçici bakteriyeminin, bazı EE vakalarının gelişiminin öncüsü olduğu düşünülmektedir. Antibiyotikler odontojenik ve nonodontojenik enfeksiyonların tedavisi dışında lokal ve fokal enfeksiyonlar için profilaksi durumlarında kullanılmaktadır. Amerikan Kalp Derneği geçmişten günümüze belli yıllarda diş hekimliği tedavi prosedürleri sırasında profilaksi ile ilgili tavsiyelerini kılavuzlar yayımlayarak güncellemektedir. 1950'lerden bu yana dental tedaviyi takiben endokarditin önlenmesinde antibiyotik kullanımında kademeli bir azalma olmuştur. 2007'den bu yana tüm güncellenen rehberlerde ağız bakımının dental prosedürlerde uygulanan antibiyotik profilaksisiden (AP) daha etkili olduğu görülmektedir. Bu kılavuzlardan en sonuncusu 2021 yılında radikal değişikliklerle güncellenmiştir. En radikal değişiklik, penisilin alerjisi olan hastalara klindamisin yerine doksisiklin yazılması olmuştur. Bu rehberde de ağız hijyeninin önemi yine vurgulanmıştır. 2021 rehberinde de dental işlemlerde oldukça az miktarda hastaya profilaksi önerilmektedir. Bu makalenin amacı, 1997 yılından 2021 yılına kadar geçen zamanda EE'yi önlemek için uygulanan AP'de meydana gelen değişiklikleri bir arada sunmak ve EE ile ilgili diş hekimlerinin genel bilgilerini tazelemektir.
Anahtar Kelimeler: Antibiyotik profilaksisi; enfektif endokardit; diş hekimliği
Infective endocarditis (IE) is a rare but life-threatening microbial infection of the heart valves or endocardium, most often associated with congenital or acquired heart defects. Oral streptococci in the normal oral flora are known to constitute 10-30% of IE cases. Transient bacteremia that occurs during poor oral hygiene, periodontal disease, dental procedures or normal daily activities (e.g. tooth brushing) is thought to be a precursor to the development of some cases of IE. Antibiotics are used in prophylaxis for local and focal infections, apart from the treatment of odontogenic and non-odontogenic infections. The American Heart Association has been updating its recommendations on prophylaxis during dental treatment procedures by publishing guidelines in certain years from past to present. Since the 1950s there has been a gradual reduction in the use of antibiotics for the prevention of endocarditis following dental treatment. In all updated guidelines since 2007, oral care seems to be more effective than antibiotic prophylaxis (AP) applied in dental procedures. The last of these guidelines was updated in 2021 with radical changes. The most radical change was the prescribing of doxycycline for patients with penicillin allergy instead of clindamycin. The importance of oral hygiene is also emphasized in this guide. In the 2021 guide, prophylaxis is recommended for a very small number of patients in dental procedures. The aim of this article is to present together the changes in AP applied to prevent IE from 1997 to 2021 and to refresh the general knowledge of dentists about IE.
Keywords: Antibiotic prophylaxis; infective endocarditis; dentistry
- Abbott PV. Selective and intelligent use of antibiotics in endodontics. Aust Endod J. 2000;26(1):30-9. [Crossref] [PubMed]
- Ahmadi H, Ebrahimi A, Ahmadi F. Antibiotic therapy in dentistry. Int J Dent. 2021;2021:6667624. [Crossref] [PubMed] [PMC]
- Cahill TJ, Harrison JL, Jewell P, Onakpoya I, Chambers JB, Dayer M, et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart. 2017;103(12):937-44. [Crossref] [PubMed]
- Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol. 2006;33(6):401-7. [Crossref] [PubMed]
- Felix JE, Rosen S, App GR. Detection of bacteremia after the use of an oral irrigation device in subjects with periodontitis. J Periodontol. 1971;42(12):785-7. [Crossref] [PubMed]
- Crociani P, Schivazappa L. La profilassi dell'endocardite infettiva nelle procedure odontoiatriche: problemi, certezze e prospettive [Antibiotic prophylaxis of infective endocarditis in dental procedures: challenges, certainties, and perspectives]. G Ital Cardiol (Rome). 2018;19(3):170-7. Italian. [PubMed]
- Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin North Am. 1993;7(1):9-19. [Crossref] [PubMed]
- Saiman L, Prince A, Gersony WM. Pediatric infective endocarditis in the modern era. J Pediatr. 1993;122(6):847-53. [Crossref] [PubMed]
- Gersony WM, Hayes CJ, Driscoll DJ, Keane JF, Kidd L, O'Fallon WM, et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. 1993;87(2 Suppl):I121-6. [PubMed]
- Prabhu SD, O'Rourke RA. Mitral valve prolapse. In: Braunwald E, Rahimtoola SH, eds. Atlas of Heart Diseases: Valvular Heart Disease. Vol. XI. 1st ed. St. Louis: Mosby-Year Book; 1997. p.10.1-10.18.
- Boudoulas H, Wooley CF. Mitral valve prolapse. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP, eds. Moss and Adams Heart Disease in Infants, Children, and Adolescents İncluding the Fetus and Young Adult. 5th ed. Baltimore: Williams & Wilkins; 1995. p.1063-86.
- Carabello BA. Mitral valve disease. Curr Probl Cardiol. 1993;18(7):423-78. [PubMed]
- Danchin N, Voiriot P, Briancon S, Bairati I, Mathieu P, Deschamps JP, et al. Mitral valve prolapse as a risk factor for infective endocarditis. Lancet. 1989;1(8641):743-5. [Crossref] [PubMed]
- MacMahon SW, Roberts JK, Kramer-Fox R, Zucker DM, Roberts RB, Devereux RB. Mitral valve prolapse and infective endocarditis. Am Heart J. 1987;113(5):1291-8. [Crossref] [PubMed]
- Devereux RB, Kramer-Fox R, Kligfield P. Mitral valve prolapse: causes, clinical manifestations, and management. Ann Intern Med. 1989;111(4):305-17. [Crossref] [PubMed]
- Stoddard MF, Prince CR, Dillon S, Longaker RA, Morris GT, Liddell NE. Exercise-induced mitral regurgitation is a predictor of morbid events in subjects with mitral valve prolapse. J Am Coll Cardiol. 1995;25(3):693-9. [Crossref] [PubMed]
- Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation. 1997;96(1):358-66. [Crossref] [PubMed]
- Dajani AS, Bawdon RE, Berry MC. Oral amoxicillin as prophylaxis for endocarditis: what is the optimal dose? Clin Infect Dis. 1994;18(2):157-60. [Crossref] [PubMed]
- Fluckiger U, Francioli P, Blaser J, Glauser MP, Moreillon P. Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci. J Infect Dis. 1994;169(6):1397-400. [Crossref] [PubMed]
- Rouse MS, Steckelberg JM, Brandt CM, Patel R, Miro JM, Wilson WR. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. Antimicrob Agents Chemother. 1997;41(8):1673-6. [Crossref] [PubMed] [PMC]
- Sande MA, Mandell GL. Antimicrobial agents-tetracyclines, chloram- phenicol, erythromycin, and miscellaneous antibacterial agents. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed. New York: Pergamon Press; 1990. p.1117-45.
- Bayer AS, Nelson RJ, Slama TG. Current concepts in prevention of prosthetic valve endocarditis. Chest. 1990;97(5):1203-7. [Crossref] [PubMed]
- Starkebaum M, Durack D, Beeson P. The "incubation period" of subacute bacterial endocarditis. Yale J Biol Med. 1977;50(1):49-58. [PubMed] [PMC]
- Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation. 1997;95(6):1686-744. [PubMed]
- Lockhart PB, Brennan MT, Fox PC, Norton HJ, Jernigan DB, Strausbaugh LJ. Decision-making on the use of antimicrobial prophylaxis for dental procedures: a survey of infectious disease consultants and review. Clin Infect Dis. 2002;34(12):1621-6. [Crossref] [PubMed]
- Durack DT. Antibiotics for prevention of endocarditis during dentistry: time to scale back? Ann Intern Med. 1998;129(10):829-31. [Crossref] [PubMed]
- Durack DT. Prophylaxis of infective endo-carditis. In: Bennet JE, Dolin R, Blaser MJ, eds. Principles and Practice of Infectious Dis- eases. 8th ed. Philadelphia: Elsevier, Sounders; 2015. p.1057-65. [Crossref]
- Lam DK, Jan A, Sándor GK, Clokie CM; American Heart Association. Prevention of infective endocarditis: revised guidelines from the American Heart Association and the implications for dentists. J Can Dent Assoc. 2008;74(5):449-53. [PubMed]
- Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(25):e1159-e95. [Crossref] [PubMed]
- ADA [Internet]. © 2023 American Dental Association [Cited: March 31, 2017]. Antibiotic prophylaxis prior to dental procedures. Available from: [Link]
- Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al; ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369-413. [Crossref] [PubMed]
- Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70(2):252-89. [Crossref] [PubMed]
- Ashraf F. Fouad Chair, B. Ellen Byrne, Anibal R. Diogenes, Christine M. Sedgley and Bruce Y. Cha. American Association Endodontist Quick Reference Guide on Antibiotic Prophylaxis 2017 Update. [Link]
- Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al; American Heart Association. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2008;139 Suppl:3S-24S. Erratum in: J Am Dent Assoc. 2008;139(3):253. [PubMed]
- Stacey D, Hill S, McCaffery K, Boland L, Lewis KB, Horvat L. Shared decision making interventions: theoretical and empirical evidence with implications for health literacy. Stud Health Technol Inform. 2017;240:263-83. [PubMed]
- Wilson WR, Gewitz M, Lockhart PB, Bolger AF, DeSimone DC, Kazi DS, et al; American Heart Association Young Hearts Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; and the Council on Quality of Care and Outcomes Research. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. Circulation. 2021;143(20):e963-e978. Erratum in: Circulation. 2021;144(9):e192. Erratum in: Circulation. 2022;145(17):e868. [Crossref] [PubMed]
- Wilson WR, Gewitz M, Lockhart PB, Bolger AF, DeSimone DC, Kazi DS, et al; American Heart Association Young Hearts Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; and the Council on Quality of Care and Outcomes Research. Adapted from: Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. J Am Dent Assoc. 2021;152(11):886-902.e2. [Crossref] [PubMed]
.: İşlem Listesi